These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11745927)

  • 1. Longitudinal study of serum neutralization of HIV-1 in infected plasma donors.
    Abelian AV; Saurya S; Ash S; Karpas A
    J Med Virol; 2001 Dec; 65(4):649-58. PubMed ID: 11745927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization.
    Georgiev IS; Doria-Rose NA; Zhou T; Kwon YD; Staupe RP; Moquin S; Chuang GY; Louder MK; Schmidt SD; Altae-Tran HR; Bailer RT; McKee K; Nason M; O'Dell S; Ofek G; Pancera M; Srivatsan S; Shapiro L; Connors M; Migueles SA; Morris L; Nishimura Y; Martin MA; Mascola JR; Kwong PD
    Science; 2013 May; 340(6133):751-6. PubMed ID: 23661761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient neutralization of primary isolates by the plasma from HIV-1 infected Indian children.
    Prakash SS; Chaudhary AK; Lodha R; Kabra SK; Vajpayee M; Hazarika A; Bagga B; Luthra K
    Viral Immunol; 2011 Oct; 24(5):409-13. PubMed ID: 22004138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What's new in HIV/AIDS? Neutralizing HIV antibodies: do they really protect?
    Jülg B; Goebel FD
    Infection; 2005 Oct; 33(5-6):405-7. PubMed ID: 16258878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization of multiple HIV-1 isolates from a single subject by autologous sequential sera.
    Tremblay M; Wainberg MA
    J Infect Dis; 1990 Sep; 162(3):735-7. PubMed ID: 2387997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement-mediated, antibody-dependent neutralizing titers of sera from asymptomatic and symptomatic HIV-infected individuals.
    Spear GT; Carlson JR; Jennings MB; Takefman DM; Landay AL
    AIDS; 1992 Sep; 6(9):1047. PubMed ID: 1388899
    [No Abstract]   [Full Text] [Related]  

  • 7. Absence of a clinical correlation for complement-mediated, infection-enhancing antibodies in plasma or sera from HIV-1-infected individuals. Multicenter AIDS Cohort Study Group.
    Montefiori DC; Lefkowitz LB; Keller RE; Holmberg V; Sandstrom E; Phair JP
    AIDS; 1991 May; 5(5):513-7. PubMed ID: 1863402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing as well as non-neutralizing polyclonal immunoglobulin (Ig)G from infected patients capture HIV-1 via antibodies directed against the principal immunodominant domain of gp41.
    Burrer R; Haessig-Einius S; Aubertin AM; Moog C
    Virology; 2005 Mar; 333(1):102-13. PubMed ID: 15708596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing antibody responses in patients with AIDS with neurologic complications.
    Beilke MA; Minagawa H; Stone G; Leon-Monzon M; Gibbs CJ
    J Lab Clin Med; 1991 Dec; 118(6):585-8. PubMed ID: 1744507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive immunotherapy in advanced HIV infection and therapeutic plasmapheresis in asymptomatic HIV-positive individuals: a four-year clinical experience.
    Blick G; Scott WF; Crook SW; Buchanan S; Garton T; Hopkins U; Vadaboncoeur AM; Doolittle J; Bulcraig IA; Greiger-Zanlungo P; Karpas A
    Biotherapy; 1998; 11(1):7-14. PubMed ID: 9617460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known Epitopes.
    Ditse Z; Muenchhoff M; Adland E; Jooste P; Goulder P; Moore PL; Morris L
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 neutralization by plasma from B or F genotype infected individuals.
    Bongertz V; Teixeira SL; Grinztejn B; Pilotto JH; Veloso VG; Morgado MG; Bastos FI; Ouverney EP
    Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):85-9. PubMed ID: 15867970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing antibodies against highly cytopathic Zairian human immunodeficiency type-1 virus (HIV-1) NDK are present in sera outside Africa.
    Machado AA; Bakpabua M; Salaun D; de Mareuil J; Krchnak V; MacGregor RR; Chermann JC; Hirsch I
    Vaccine; 1995 Feb; 13(3):321-5. PubMed ID: 7631521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments.
    Hraber P; Rademeyer C; Williamson C; Seaman MS; Gottardo R; Tang H; Greene K; Gao H; LaBranche C; Mascola JR; Morris L; Montefiori DC; Korber B
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28747500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of neutralizing antibodies in HIV infection.
    Humbert M; Dietrich U
    AIDS Rev; 2006; 8(2):51-9. PubMed ID: 16848273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-neutralizing anti-HIV-1 human single chain variable fragments(scFvs) against CD4 binding site and N332 glycan identified from a recombinant phage library.
    Khan L; Kumar R; Thiruvengadam R; Parray HA; Makhdoomi MA; Kumar S; Aggarwal H; Mohata M; Hussain AW; Das R; Varadarajan R; Bhattacharya J; Vajpayee M; Murugavel KG; Solomon S; Sinha S; Luthra K
    Sci Rep; 2017 Mar; 7():45163. PubMed ID: 28332627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
    Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
    J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of neutralizing and enhancing antibodies to human immunodeficiency virus type 1 primary isolates in plasma of individuals infected with env Genetic subtype B and E viruses in Thailand.
    Auewarakul P; Louisirirotchanakul S; Sutthent R; Taechowisan T; Kanoksinsombat C; Wasi C
    Viral Immunol; 1996; 9(3):175-85. PubMed ID: 8890476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors.
    Bradney AP; Scheer S; Crawford JM; Buchbinder SP; Montefiori DC
    J Infect Dis; 1999 May; 179(5):1264-7. PubMed ID: 10191234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of antibodies to the gp120 V3 region principal neutralizing determinant of HIV-1MN in sera from Africa and the Americas.
    Carrow EW; Vujcic LK; Glass WL; Seamon KB; Rastogi SC; Hendry RM; Boulos R; Nzila N; Quinnan GV
    AIDS Res Hum Retroviruses; 1991 Oct; 7(10):831-8. PubMed ID: 1720630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.